Qifangfeixian Granules
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Qifangfeixian Granules, covering 2024-11-05 to 2024-11-05. Get the full timeline:
Most recent: Clinical Trial Update: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of the Efficacy and Safety of Qifangfeixian Granules in the Treatment of Connective Tissue Disease-Associated Interstitial Lung Disease (CTD-ILD) [Phase 2, Phase 3]